## Evidence-Based Management of Xerophthalmia **Key Point:** Xerophthalmia management combines acute high-dose vitamin A therapy for symptomatic cases and population-level prevention through supplementation and fortification. Surgical intervention is **not** a first-line or primary management strategy. ### Correct Interventions (Options 0, 1, 2) **Option 0 — High-Dose Vitamin A Therapy:** - WHO-recommended dosing for children with corneal involvement: - Day 1: 200,000 IU (60 mg retinol equivalent) orally - Day 2: 200,000 IU - Day 14: 200,000 IU (to replenish liver stores) - This regimen arrests corneal ulceration and prevents perforation - Dosing is based on age and severity, not on whether scarring is already present [cite:Park 26e Ch 8] **Option 1 — Universal Supplementation Programs:** - WHO recommends vitamin A supplementation for **all children aged 6–59 months** in vitamin A-deficient regions - Dosing: 100,000–200,000 IU twice yearly (or adjusted for age) - This is **independent of clinical signs** and is a population-level prevention strategy - Has been shown to reduce child mortality by 12–24% in endemic areas [cite:Harrison 21e Ch 429] - Does not require individual clinical assessment **Option 2 — Food Fortification:** - Fortification of staple foods (rice, wheat flour, cooking oil, sugar) with vitamin A is a **sustainable, long-term public health approach** - Reaches populations who may not access supplementation programs - WHO and national health agencies endorse fortification as a cornerstone of xerophthalmia prevention - Cost-effective and does not require repeated dosing campaigns ### Incorrect Intervention (Option 3) — **CORRECT ANSWER** **Option 3 — Immediate Corneal Transplantation:** - This statement is **FALSE** and represents a misunderstanding of xerophthalmia management - Corneal transplantation is **not** a first-line or primary intervention for xerophthalmia-related scarring - Reasons: 1. **Vitamin A must be repleted first** — the underlying deficiency must be corrected before any surgical intervention 2. **Graft survival is poor** in the setting of active vitamin A deficiency (poor epithelialization, recurrent ulceration) 3. **Transplantation is reserved for visual rehabilitation** after vitamin A repletion and only in cases of dense scarring with significant visual impairment 4. **Immediate transplantation is contraindicated** — the eye is still in a "hostile" metabolic state - The sequence is: vitamin A repletion → stabilization of ocular surface → delayed surgical rehabilitation if needed **Warning:** A common exam trap is confusing the **timing and role** of surgery. Corneal transplantation may eventually be needed for visual rehabilitation, but it is **never** the first step and is not a primary management intervention for acute xerophthalmia. **High-Yield:** The management pyramid for xerophthalmia is: 1. **Prevention** (supplementation, fortification) 2. **Early detection and vitamin A therapy** (arrests progression) 3. **Surgical rehabilitation** (only after repletion and stabilization) ### Management Algorithm ```mermaid flowchart TD A[Child with suspected xerophthalmia]:::outcome --> B{Clinical stage?}:::decision B -->|Night blindness only| C[Vitamin A 200,000 IU once]:::action B -->|Bitot's spots/conjunctival xerosis| D[Vitamin A 200,000 IU × 2 days, then day 14]:::action B -->|Corneal involvement| E[High-dose Vitamin A therapy]:::urgent E --> F[Stabilize ocular surface]:::action F --> G{Dense scarring + vision loss?}:::decision G -->|Yes, after repletion| H[Consider delayed corneal transplant]:::action G -->|No| I[Continue vitamin A + supportive care]:::action C --> J[Population supplementation + fortification]:::action D --> J I --> J ``` **Clinical Pearl:** In endemic regions, the focus is on **prevention through population programs**, not on surgical rescue. A child who develops corneal scarring represents a failure of the prevention system, not a case for immediate transplantation.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.